Home Tools
Log in
Cart

Search Result

Search Results for " hts "

Targets

11

Compounds

1

Natural Products

3

Recombinant Proteins

69

Libraries

Cat No. Product Name Synonyms Targets
T16275 NB001 HTS 09836 Adenylyl cyclase
NB001 (HTS 09836) is an inhibitor of adenyl cyclase 1 exhibiting effects on neural and non-neural pain.
T2048 LY-364947 LY 364947,HTS466284 MLK , Casein Kinase , TGF-beta/Smad , RIP kinase
LY-364947 (HTS466284) is a potent ATP-competitive inhibitor of TGFβR-I.
T32453 L 650719 6-HTS,L650719,L-650719
L 650719 is a bioactive chemical.
T15506 HTS01037 Others
HTS01037 is an inhibitor of fatty acid-binding. HTS01037 is a competitive antagonist of protein-protein interactions mediated by AFABP/aP2 (Ki: 0.67 μM).
T61316 HTS07545 NADPH
HTS07545 is a potent sulfide:quinone oxidoreductase inhibitor (IC50: 30 nM).HTS07545 reduces the rate of hydrogen sulfide (H2S) decomposition.HTS07545 has been used in heart failure studies.
T34055 Phtstllap
Phtstllap is a luteinizing hormone-releasing factor
T4178 NSC 80538 Others
NSC 80538 is an inhibitor of MEK Kinase PB1 Domains in multiplex HTS assays.
T4531 GSK2200150A Antibacterial
GSK2200150A is an anti-tuberculosis (TB) agent identified by high-throughput screening (HTS) campaign.
T9256 N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine Serine/threonin kinase , PKC
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine is a novel 2,6-naphthyridine identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor[1].
T8411 C-215 Others
C-215 is a novel inhibitor of mycobacterial membrane protein large 3 (MmpL3).
T83800 6-Biotin-17-NAD+ sodium 6-Biotin-17-Nicotinamide adenine dinucleotide,β-Nicotinamide-N6-(2-(6-(6-[biotinyl]aminohexanoyl)aminohexanoyl)aminoethyl)adenine dinucleotide
6-Biotin-17-NAD+, a biotinylated derivative of the signaling molecule and enzyme cofactor NAD+, is utilized in high-throughput screening (HTS) assays to measure the activity of mitochondrial complex I, also referred to a...
Cat No. Product Name Synonyms Targets
T6808 Coelenterazine Oplophorus luciferin,Coelenteramine Others
Coelenterazine (Coelenteramine) is a luminescent enzyme substrate, used for monitoring reporter genes in BRET, ELISA and HTS techniques.

Recombinant Proteins

Cat No. Product Name Species Expression System
TMPK-00311 APCDD1 Protein, Human, Recombinant (His) Human HEK293 Cells
APCDD1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 54.4 kDa and the accession number is Q8J025.
TMPK-00989 APCDD1 Protein, Mouse, Recombinant (His) Mouse HEK293 Cells
APCDD1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 54.4 kDa and the accession number is Q3U128.
TMPY-03046 APCDD1 Protein, Human, Recombinant (hFc) Human HEK293 Cells
Osteosarcoma (OS) is the most common type of bone tumor in children and adults. The expression of APCDD1, a Wnt antagonist, was reduced in OS tissues and cells compared to adjacent normal tissue and osteoblast cells, res...
Cat No. Product Name
L6000 Natural Product Library for HTS

4533 compounds
A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can...
L7000 Bioactive Lipid Compound Library

385 compounds
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ...
L1000 Approved Drug Library

2808 compounds
A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);
L2530 Mouse Metabolite Compound Library

218 compounds
A unique collection of 218 mouse metabolites, which can be used for HTS and HCS;
L5610 Golden Scaffold Library

10000 compounds
Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source;
L5700 Featured Fragment Library

246 compounds
A unique collection of 246 fragment-like small molecules for FBDD;
LF1000 Pre-plated Diversity Sets

50000 compounds
For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap.
L3410 Preclinical Compound Library

701 compounds
A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);
L6100 Polyphenolic Natural Product Library

635 compounds
A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);
L3900 DNA Damage & Repair Compound Library

910 compounds
A unique collection of 910 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);
L5500 Toxic Compound Library

262 compounds
A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);
L8800 Drug-Fragment Library

1119 compounds
1119 drug fragments,a must-have tool for FBDD;
L9200 Drug Repurposing Compound Library

4541 compounds
A unique collection of 4541 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L3980 DNA Damage and Repair Compound Library Plus

667 compounds
Well-chosen 667 compounds with unique structures targeting DNA damage & repair;
L1010 FDA-Approved & Pharmacopeia Drug Library

3157 compounds
3157 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);
L4200 FDA-Approved Drug Library

1729 compounds
A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);
L5200 Anti-Metabolism Disease Compound Library

1544 compounds
A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L3400 Clinical Compound Library

3404 compounds
A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
L6700 Anti-Tumor Natural Product Library

1772 compounds
A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L6010 Natural Product Library

3840 compounds
A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS);
L5800 Drug Metabolite/Impurity Library

197 compounds
A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);
L2620 Anti-Neurodegenerative Disease Compound Library

2154 compounds
A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS;
L6160 RO5 Drug-like Natural Product Library

2703 compounds
A unique collection of 2703 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening;
L9820 Beta-Lactam Compound Library

97 compounds
A unique collection of 97 beta-lactam compounds, can be used in HTS and HCS;
L2000 Inhibitor Library

8328 compounds
A unique collection of 8328 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L6610 Anti-infective Natural Product Library

1060 compounds
A unique collection of 1060 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);
L2150 Anti-Cancer Drug Library

3080 compounds
A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
L6900 Rare Natural Product Library

693 compounds
A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);
L3200 Autophagy Compound Library

1248 compounds
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L3500 Histone Modification Compound Library

469 compounds
A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);
L2400 Endocrinology-Hormone Compound Library

784 compounds
A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L9810 Anti-Fibrosis Compound Library

1180 compounds
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;
L5900 CNS-Penetrant Compound Library

509 compounds
A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);
L4800 Angiogenesis related Compound Library

1353 compounds
A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L1200 Epigenetics Compound Library

953 compounds
Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L2160 Anti-Cancer Active Compound Library

3188 compounds
A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L2192 Anti-Pancreatic Cancer Compound Library

2238 compounds
A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS;
L5400 Anti-Cardiovascular Disease Compound Library

1408 compounds
A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L2100 Anti-Cancer Compound Library

7234 compounds
A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L2120 Anti-Cancer Clinical Compound Library

2545 compounds
A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);
L6620 Antiparasitic Natural Product Library

253 compounds
A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);
L6600 Anti-Gastroenteritis Natural Product Library

219 compounds
A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);
L8200 Anti-Aging Compound Library

3279 compounds
A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);
L8300 Chromatin Modification Compound Library

250 compounds
A unique collection of 250 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);
L8100 Cell Cycle Compound Library

677 compounds
A unique collection of 677 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
L6140 Saccharide and Glycoside Natural Product Library

362 compounds
A unique collection of 362 saccharides and glycosides compounds can be used for HTS and HCS;
L8400 Hematonosis Compound Library

514 compounds
A unique collection of 514 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);
L4000 Bioactive Compound Library

14439 compounds
A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;
L2110 Anti-Cancer Approved Drug Library

1779 compounds
A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
L7500 Coagulation and Anticoagulation Compound Library

144 compounds
A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);
L2600 Neuronal Signaling Compound Library

2540 compounds
A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L3300 Histamine & Melatonin Receptor-Targeted Compound Library

153 compounds
A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L9700 Endoplasmic Reticulum Stress Compound Library

193 compounds
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);
L5100 Fluorochemical Library

574 compounds
A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);
L1110 Microtubule-Targeted Compound Library

142 compounds
A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS;
L2130 Anti-Cancer Metabolism Compound Library

1268 compounds
A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
L2520 Glycometabolism Compound Library

702 compounds
702 glycometabolism-related comounds, can be used for HTS and HCT;
L2510 Lipid Metabolism Compound Library

492 compounds
A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L2540 Gut Microbial Metabolite Library

607 compounds
A unique collection of 607 gut microbial metabolites which can be used for HTS and HCS;
L5510 Drug-induced Liver Injury (DILI) Compound Library

1001 compounds
A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening;
L4600 Selected Plant-Sourced Compound Library

3048 compounds
A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L2610 Neurotransmitter Receptor Compound Library

1513 compounds
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening;
L1310 Cytoskeletal Signaling Pathway Compound Library

759 compounds
A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS;
L9830 Anti-Parkinson's Disease Compound Library

857 compounds
A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
L6400 Marine Natural Product Library

144 compounds
A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS);
L6500 Microbial Natural Product Library

550 compounds
A unique collection of 550 microbial natural products for high throughput screening (HTS) and high content screening (HCS);
L6720 Anti-COVID-19 Traditional Chinese Medicine Compound Library

1147 compounds
A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening;
L9840 Anti-Alzheimer's Disease Compound Library

986 compounds
A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.
L2550 Glutamine Metabolism Compound Library

565 compounds
A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ...

Libraries

Natural Product Library for HTS
L6000
Compounds: 4533
Bioactive Lipid Compound Library
L7000
Compounds: 385
Approved Drug Library
L1000
Compounds: 2808
Mouse Metabolite Compound Library
L2530
Compounds: 218
Golden Scaffold Library
L5610
Compounds: 10000
Featured Fragment Library
L5700
Compounds: 246
Pre-plated Diversity Sets
LF1000
Compounds: 50000
Preclinical Compound Library
L3410
Compounds: 701
Polyphenolic Natural Product Library
L6100
Compounds: 635
DNA Damage & Repair Compound Library
L3900
Compounds: 910
Toxic Compound Library
L5500
Compounds: 262
Drug-Fragment Library
L8800
Compounds: 1119
Drug Repurposing Compound Library
L9200
Compounds: 4541
DNA Damage and Repair Compound Library Plus
L3980
Compounds: 667
FDA-Approved & Pharmacopeia Drug Library
L1010
Compounds: 3157
FDA-Approved Drug Library
L4200
Compounds: 1729
Anti-Metabolism Disease Compound Library
L5200
Compounds: 1544
Clinical Compound Library
L3400
Compounds: 3404
Anti-Tumor Natural Product Library
L6700
Compounds: 1772
Natural Product Library
L6010
Compounds: 3840
Drug Metabolite/Impurity Library
L5800
Compounds: 197
Anti-Neurodegenerative Disease Compound Library
L2620
Compounds: 2154
RO5 Drug-like Natural Product Library
L6160
Compounds: 2703
Beta-Lactam Compound Library
L9820
Compounds: 97
Inhibitor Library
L2000
Compounds: 8328
Anti-infective Natural Product Library
L6610
Compounds: 1060
Anti-Cancer Drug Library
L2150
Compounds: 3080
Rare Natural Product Library
L6900
Compounds: 693
Autophagy Compound Library
L3200
Compounds: 1248
Histone Modification Compound Library
L3500
Compounds: 469
Endocrinology-Hormone Compound Library
L2400
Compounds: 784
Anti-Fibrosis Compound Library
L9810
Compounds: 1180
CNS-Penetrant Compound Library
L5900
Compounds: 509
Angiogenesis related Compound Library
L4800
Compounds: 1353
Epigenetics Compound Library
L1200
Compounds: 953
Anti-Cancer Active Compound Library
L2160
Compounds: 3188
Anti-Pancreatic Cancer Compound Library
L2192
Compounds: 2238
Anti-Cardiovascular Disease Compound Library
L5400
Compounds: 1408
Anti-Cancer Compound Library
L2100
Compounds: 7234
Anti-Cancer Clinical Compound Library
L2120
Compounds: 2545
Antiparasitic Natural Product Library
L6620
Compounds: 253
Anti-Gastroenteritis Natural Product Library
L6600
Compounds: 219
Anti-Aging Compound Library
L8200
Compounds: 3279
Chromatin Modification Compound Library
L8300
Compounds: 250
Cell Cycle Compound Library
L8100
Compounds: 677
Saccharide and Glycoside Natural Product Library
L6140
Compounds: 362
Hematonosis Compound Library
L8400
Compounds: 514
Bioactive Compound Library
L4000
Compounds: 14439
Anti-Cancer Approved Drug Library
L2110
Compounds: 1779
Coagulation and Anticoagulation Compound Library
L7500
Compounds: 144
Neuronal Signaling Compound Library
L2600
Compounds: 2540
Histamine & Melatonin Receptor-Targeted Compound Library
L3300
Compounds: 153
Endoplasmic Reticulum Stress Compound Library
L9700
Compounds: 193
Fluorochemical Library
L5100
Compounds: 574
Microtubule-Targeted Compound Library
L1110
Compounds: 142
Anti-Cancer Metabolism Compound Library
L2130
Compounds: 1268
Glycometabolism Compound Library
L2520
Compounds: 702
Lipid Metabolism Compound Library
L2510
Compounds: 492
Gut Microbial Metabolite Library
L2540
Compounds: 607
Drug-induced Liver Injury (DILI) Compound Library
L5510
Compounds: 1001
Selected Plant-Sourced Compound Library
L4600
Compounds: 3048
Neurotransmitter Receptor Compound Library
L2610
Compounds: 1513
Cytoskeletal Signaling Pathway Compound Library
L1310
Compounds: 759
Anti-Parkinson's Disease Compound Library
L9830
Compounds: 857
Marine Natural Product Library
L6400
Compounds: 144
Microbial Natural Product Library
L6500
Compounds: 550
Anti-COVID-19 Traditional Chinese Medicine Compound Library
L6720
Compounds: 1147
Anti-Alzheimer's Disease Compound Library
L9840
Compounds: 986
Glutamine Metabolism Compound Library
L2550
Compounds: 565
TargetMol